Identität

Calcium Levofolinate Impurity 22

Nicht angegeben · C19H21N7O6

01Identität

Lazychem IDLC-34583
CAS RNNicht angegeben
PubChem CID136670097
Molecular formulaC19H21N7O6
Molecular weight443.4 g/mol
IUPAC name(2S)-2-[[4-[(2-amino-4-oxo-5,6-dihydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
InChIKeyXMYXXFPKFWSFBU-KIYNQFGBSA-N

02Struktur und Stereochemie

Two-dimensional chemical structure of Calcium Levofolinate Impurity 22
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count3
Secondary amines2
Tertiary amines0
SMILESC1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2C=NC3=C(N2)C(=O)NC(=N3)N
InChINicht angegeben

03Stereochemistry

The published structure contains 1 defined and 1 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres1Structure unspecified
Assignment statusPartially assignedExact published identity
Tetrahedral upper bound≤ 4Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status in Indien

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Namen und Beziehungen

API und Ausgangsarzneistoff

Nicht angegeben

Namen und Beziehungen

    06Quellen